By Sherri Oslick —

About
Court Report:  Each week we will report briefly on recently filed
biotech and pharma cases, and a few interesting cases will be selected
for periodic monitoring.

Sepracor Inc. and University of Massachusetts v. Pharmaceutical Associates, Inc.
3:08-cv-04718; filed September 19. 2008 in the District Court of New Jersey

Infringement of U.S. Patent Nos. 7,214,683 ("Compositions of Descarboethoxyloratadine," issued May 8, 2007) and 7,214,684 ("Methods for the Treatment of Allergic Rhinitis," issued May 8, 2007), licensed to Schering-Plough, following a Paragraph IV certification as part of Sandoz’s filing of an ANDA to manufacture a generic version of Schering-Plough’s Clarinex® Oral Syrup (desloratidine, used to treat allergies).  View the complaint here.

Bayer Schering Pharma AG et al. v. Sandoz, Inc. et al.
1:08-cv-08112; filed September 18, 2008 in the Southern District of New York

Infringement of U.S. Patent No. 5,569,652 ("Dihydrospirorenone as an antiandrogen," issued October 29, 1996) following a Paragraph IV certification as part of defendants’ filing of an ANDA to manufacture a generic version of Bayer’s Yaz® (drospirenone & ethinyl estradiol, used for oral contraception).  View the complaint here.